LEMD2 activators comprise chemicals known to impact intricate cellular pathways, which may, in turn, have an influence on LEMD2, a protein associated with various cellular processes. Notable among these are Forskolin and 8-Br-cAMP, which modulate intracellular cAMP levels. These chemicals highlight the importance of cAMP in the regulation of numerous cellular processes, suggesting the potential of cAMP-modulating agents to indirectly affect LEMD2.
Concurrently, the role of kinase pathways in influencing LEMD2 is underscored by agents like PMA, LY294002, and U0126, which target protein kinase C, PI3K, and MAPK/ERK pathways, respectively. The variety of these activators, spanning from growth factors like EGF to mTOR inhibitors such as Rapamycin, provides a comprehensive overview of the chemical agents that can shape LEMD2's behavior within a cellular milieu.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, which can activate numerous cellular pathways, potentially affecting LEMD2. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates the cAMP-dependent pathway, which can indirectly influence LEMD2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Acts as a diacylglycerol (DAG) analog and activates protein kinase C (PKC), which could influence LEMD2's associated pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Modulates intracellular calcium levels, activating calcium-related signaling cascades that can influence LEMD2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor; it can modulate the phosphoinositide 3-kinase (PI3K) pathway, which might influence proteins associated with LEMD2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK and influences the p38 MAPK signaling pathway, which might indirectly affect LEMD2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that offers a different mode of action to modulate the PI3K pathway, potentially influencing LEMD2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, it impacts the MAPK signaling pathway, which could have an indirect effect on LEMD2. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
An EGFR tyrosine kinase inhibitor that modulates EGFR signaling, which can influence LEMD2. | ||||||